We present a paradoxical case of immune thrombocytopenia (ITP) that presented with cerebral venous thrombosis. A 39-year-old female patient diagnosed with chronic ITP, who failed treatment on multiple-line agents, was started on eltrombopag (thrombopoietin receptor agonist), which she was not compliant to. The patient later developed extensive cerebral venous thrombosis, along with venous infarcts, and intracranial and subarachnoid hemorrhage. She was treated with intravenous immunoglobulins as well as steroid therapy and was simultaneously started on anticoagulation. The patient improved clinically and radiologically. This case is among few reported cases which signify that patients with ITP are inherently prone to thrombosis despite low platelet count and treating these patients can be a dilemma. Judicious use of anticoagulation and immunosuppressive therapy is recommended based on available evidence pending further recommendations and guidelines about treatment of thrombosis in ITP.
CITATION STYLE
Rasheed, M. A., Alsaud, A. E., Razzaq, S., Fadul, A., & Yassin, M. A. (2020). Cerebral Venous Thrombosis in a Patient with Immune Thrombocytopenia, an Apparent Paradox. Case Reports in Oncology, 13(2), 588–594. https://doi.org/10.1159/000507389
Mendeley helps you to discover research relevant for your work.